Registry for treating coronary bifurcation lesions
Prospective Global Registry of Percutaneous Coronary Intervention in Bifurcation Lesions (PROGRESS-BIFURCATION)
This study collects information on how different treatment methods for coronary bifurcation lesions work for patients getting heart procedures, to see which approaches are most effective.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 4000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Minneapolis Heart Institute Foundation Academic / other |
| Locations | 1 site (Minneapolis, Minnesota) |
| Trial ID | NCT05100992 on ClinicalTrials.gov |
What this trial studies
This observational registry collects data on treatment strategies and outcomes for patients undergoing percutaneous coronary interventions (PCI) for coronary bifurcation lesions. It aims to document the frequency of these procedures and the various techniques employed, including both single and dual stent approaches. By analyzing outcomes across multiple centers, the study seeks to provide insights into the effectiveness of different treatment strategies for these challenging lesions.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old who are undergoing bifurcation percutaneous coronary intervention.
Not a fit: Patients not undergoing bifurcation PCI or those under 18 years old may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve treatment approaches and outcomes for patients with coronary bifurcation lesions.
How similar studies have performed: While there have been studies on bifurcation lesions, this registry approach to gather comprehensive data on treatment strategies is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Over 18 years of age * undergoing bifurcation percutaneous coronary intervention
Where this trial is running
Minneapolis, Minnesota
- Minneapolis Heart Institute Foundation — Minneapolis, Minnesota, United States (Recruiting)
Study contacts
- Study coordinator: Emmanouil Brilakis, MD, PhD
- Email: emmanouil.brilakis@allina.com
- Phone: 612-863-3852
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.